Register

Support: 888-992-3836|NewsWire|Home|Login / Register

Home > Boards > US Listed > Medical - Drugs > Cancer Genetics Inc. (CGIX)

Do you have evidence of a Merger? The

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

Millermanagement

Followed By	0
Posts	91
Boards Moderated	0
Alias Born	08/26/17

160x600 placeholder

Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 5:13:22 PM

Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 7:02:08 PM

Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 7:01:14 PM

Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 6:59:47 PM

Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 6:55:39 PM

Cancer Genetics and StemoniX Announce Merger Closing GlobeNewswire Inc. - 3/31/2021 6:30:00 AM

Cancer Genetics stock up on shareholder approval for Stemonix deal Seeking Alpha - 3/25/2021 9:59:32 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2021 9:17:51 AM

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/25/2021 9:16:05 AM

Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX GlobeNewswire Inc. - 3/25/2021 9:15:00 AM

Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development GlobeNewswire Inc. - 3/18/2021 8:30:00 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 3/16/2021 7:03:03 AM

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/16/2021 7:00:55 AM

Cancer Genetics to Present at the Annual 33rd ROTH Conference GlobeNewswire Inc. - 3/12/2021 9:30:00 AM

Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire Inc. - 3/4/2021 4:15:00 PM

Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 2/26/2021 4:51:54 PM

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 2/26/2021 4:47:07 PM

Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 5:00:23 PM

Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 2/16/2021 4:45:00 PM

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/16/2021 6:38:36 AM

Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/16/2021 6:38:29 AM

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/11/2021 6:08:15 AM

Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2021 6:07:32 AM

Cancer Genetics to raise $17.5M via stock offering Seeking Alpha - 2/10/2021 11:46:47 PM

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 2/10/2021 11:00:00 PM

Millermanagement	Wednesday, 10/16/19 02:36:30 AM
Re: sindram post# 720
Post # of 924

Do you have evidence of a Merger? The only this I see is a cancelled merger with NovellusDx December 17, 2018. See below the article link. Thoughts? Any word anyone can find on a new Merger with a new company? How about a restart in talks with NovellusDx?

https://www.cancergenetics.com/cancer-genetics-terminates-proposed-merger-with-novellusdx/

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

Follow Board

Keyboard Shortcuts

Report TOS Violation

X


Current Price
Change
Volume
Detailed Quote - Discussion Board

+/- to Watchlist

Consent Preferences